Hedge Fund - Perceptive Advisors

Joseph Edelman's fund Perceptive Advisors continues its bullish streak on AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) disclosing increasing its position to over 6.57 million shares, after reporting buying...

Joseph Edelman's fund, Perceptive Advisors, in a new filing reported increasing its position in AcelRx Pharmaceuticals Inc (NASDAQ:ACRX) again, after disclosing a buy of around 360,700 shares a couple...